Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in Parkinson's Disease (PD) Without Dementia (Lab2Life)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Erin Foster, Washington University
ClinicalTrials.gov Identifier:
NCT00917280
First received: June 8, 2009
Last updated: March 25, 2014
Last verified: March 2014

June 8, 2009
March 25, 2014
December 2008
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00917280 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in Parkinson's Disease (PD) Without Dementia
Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in PD Without Dementia

The overall purpose of this research is to learn how Parkinson's disease affects thinking and memory in everyday life. Participation will involve thinking tests, questionnaires and interviews about thinking and activities in everyday life.

The overall purpose of this research is to learn how Parkinson's disease affects thinking and memory in everyday life. Participation will involve thinking tests, questionnaires and interviews about thinking and activities in everyday life.

Observational
Observational Model: Case Control
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

Controls:

Recruited from community, VFH.

Parkinson's Disease
Not Provided
  • Parkinson's Disease
    Parkinson Disease participants without dementia
  • Control
    Non-PD participants, matched for age, education and gender.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
180
Not Provided
Not Provided

Inclusion Criteria PD participants:

  • WUSM Movement Disorders Clinic patients
  • males or females between 40 and 70
  • meet criteria for idiopathic typical PD
  • classified at Hoehn & Yahr12 stage I, II, or III
  • are currently treated with levodopa/carbidopa

Inclusion Criteria Control:

  • The groups will be matched for age, education and gender
  • No Parkinson Disease

Exclusion Criteria PD participants and Control:

  • suspected dementia
  • treatment with certain dopaminergic, anticholinergic or benzodiazepine medications
  • other neurological problems
  • brain surgery
  • history or current psychotic disorder
  • any condition which would interfere with testing
  • control only: a biological family history of PD and being a caregiver or spouse of someone who has PD
Both
40 Years to 70 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00917280
#E07-117
No
Erin Foster, Washington University
Washington University School of Medicine
Not Provided
Principal Investigator: Erin Foster Washington University School of Medicine
Washington University School of Medicine
March 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP